sglt2 inhibitors and glp-1 receptor agonists inhibitors: a couple at last? Perspectives in weight control in
Description
Inclusion and Exclusion Criteria The Institution Board Review Committee at the Charleston Area Medical Center has approved this study (IRB Number: 23-956)
Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y, et al
One reason these drugs are so effective in treating obesity could be that they address the underlying addiction
Nature website
This review aims to discuss the mechanisms, pleiotropic effects, and therapeutic potential of GLP-1, DPP-4, and SGLT2, with a particular focus on their cardiorenal benefits beyond glycemic control
